Genetic factors play a role in some heart and vascular diseases. The CardioNext® and CardioScreen® tests investigate genetic changes associated with cardiovascular predisposition or inherited heart diseases. When evaluated together with the person's clinical findings and family history, the results can contribute to diagnosis, follow-up and risk assessment of family members.
The appropriate test is selected according to the person's symptoms and family history. The detection of a genetic predisposition does not necessarily mean that the disease will develop; a negative result does not completely rule out the risk of heart disease.
CardioNext® — Cardiovascular Genetic Predisposition Panel
Examines selected genetic variants involved in processes related to heart and vascular health, such as lipid metabolism, blood pressure and coagulation. The findings are evaluated together with cholesterol, blood pressure, lifestyle and family history. These polymorphisms alone do not predict cardiovascular risk; risk is assessed with cholesterol, blood pressure, smoking and diabetes.
CardioScreen® — Cardiomyopathy Panel
Investigates genes associated with inherited diseases that affect the structure and function of the heart muscle. It can help identify the genetic cause of heart muscle disease and evaluate family members.
CardioScreen® — Inherited Heart Diseases Associated with Sudden Cardiac Arrest Panel
Examines genes associated with inherited rhythm disorders and heart muscle diseases that can lead to sudden cardiac arrest. In suitable patients, it can support the planning of personalized follow-up and preventive measures.
During working hours, you can quickly apply with a simple blood test by visiting our Nicosia or Kyrenia laboratory branches.